Cara Therapeutics (NASDAQ:CARA) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Cara Therapeutics (NASDAQ:CARA – Free Report) in a research report sent to investors on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Cara Therapeutics Trading Up 13.3 % Shares of Cara Therapeutics stock opened at $5.55 on Monday. The company’s 50-day moving average price is […]
More Stories
Kyiv Mayor Says Ukraine May Have to Temporarily Cede Land to Secure Peace
By Guy Birchall The mayor of Kyiv, Vitali Klitschko, said Ukraine may, temporarily, have to cede land as part of...
US, South Korea Agree to Pursue Trade Deal Ahead of Tariff Deadline
By Aldgra Fredly South Korea and the United States agreed on Thursday to pursue a trade deal that will help...
Stifel Nicolaus Cuts Meta Platforms (NASDAQ:META) Price Target to $628.00
Meta Platforms (NASDAQ:META – Get Free Report) had its price target decreased by equities research analysts at Stifel Nicolaus from...
Needham & Company LLC Reiterates “Underperform” Rating for Meta Platforms (NASDAQ:META)
Meta Platforms (NASDAQ:META – Get Free Report)‘s stock had its “underperform” rating restated by investment analysts at Needham & Company...
Raymond James Financial Inc. Takes Position in Monarch Casino & Resort, Inc. (NASDAQ:MCRI)
Raymond James Financial Inc. acquired a new stake in shares of Monarch Casino & Resort, Inc. (NASDAQ:MCRI – Free Report)...
Critical Review: NET Power (NPWR) & The Competition
NET Power (NYSE:NPWR – Get Free Report) is one of 21 public companies in the “Electrical industrial apparatus” industry, but...